Ton Strategy Co

Análisis de la acción Ton Strategy Co (TONX)

$3.250

-0.162 (-4.97%)Al cierre

Loading chart…
High
3.570
Open
3.380
VWAP
3.35
Vol
275.88K
Mkt Cap
Low
3.240
Amount
925.13K
EV/EBITDA, TTM
169.54

Ton Strategy Company, formerly, Verb Technology Company, Inc. focuses on social commerce, social telehealth and social crowdfunding with MARKET.live, VANITYPrescribed, GoodGirlRx and the GO FUND YOURSELF TV Show. MARKET.live specializes in livestream and artificial intelligence (AI)-powered social commerce. MARKET.live platform is a multi-vendor, livestream social shopping destination at the forefront of the convergence of e-commerce and entertainment, where brands, retailers, creators, and influencers engage their customers, clients, fans, and followers across multiple social media channels simultaneously. GO FUND YOURSELF is an interactive social crowd funding platform and TV show for public and private companies seeking broad-based exposure across social media channels for their crowd-funded Regulation CF and Regulation A issuers; and a telehealth business unit that comprises two wellness-focused ecommerce sites, VanityPrescribed and GoodGirlRX.

AI analysis of Ton Strategy Co (TONX)

buy

Ton Strategy Co (TONX) is a good buy right now due to its current price of 3.25, which is significantly below its Fibonacci resistance levels, particularly the R1 at 3.425. The stock has shown a 5-day change of +6.21% and a year-to-date change of +34.85%, indicating positive momentum. Additionally, the company has initiated a buyback program under a $250 million authorization, which is expected to enhance shareholder value and reflects management's confidence in the stock's undervaluation. However, the main risk is the negative earnings trend, with a net income loss of -91,038,000 in Q1 2026, which investors should monitor closely.

Métricas de valoración

The current forward P/E ratio for Ton Strategy Co (TONX) is 0.00, compared to its 5-year average forward P/E of -1.22.

Forward P/E

Overvalued
5Y Average P/E
-1.22
Current P/E
0.00
Sobrevalorada
-0.33
Infravalorada
-2.10

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
-28.67
Current EV/EBITDA
169.54
Sobrevalorada
30.53
Infravalorada
-87.86

Forward P/S

Fair
5Y Average P/S
33.56
Current P/S
23.54
Sobrevalorada
69.38
Infravalorada
-2.26

Whales holding TONX

R

Ribbit Management Company, LLC

+ HoldingTONX

+9.24%

3M Return

A

Aristeia Capital, LLC

+ HoldingTONX

+3.11%

3M Return

V

Vy Capital

+ HoldingTONX

-23.17%

3M Return

Cronología de eventos

2026-07-16 (ET)

09:00:00

TON Strategy Expects $4M Financial Benefit in Q2 2026

2026-07-01 (ET)

08:30:00

TON Strategy Launches 2-Month Stock Repurchase Plan

2026-04-16 (ET)

16:10:00

TON Strategy Company Appoints Kevin Wilson as CEO

2026-03-31 (ET)

11:30:00

Bitfarms Achieves 72% Revenue Growth Ahead of Rebrand

2026-01-08 (ET)

09:00:00

TON Strategy Company Appoints Mary Marbach as General Counsel

Noticias

TONX FAQ — answered by Alphio AI

Ton Strategy Company, formerly, Verb Technology Company, Inc. focuses on social commerce, social telehealth and social crowdfunding with MARKET.live, VANITYPrescribed, GoodGirlRx and the GO FUND YOURSELF TV Show. MARKET.live specializes in livestream and artificial intelligence (AI)-powered social commerce. MARKET.live platform is a multi-vendor, livestream social shopping destination at the forefront of the convergence of e-commerce and entertainment, where brands, retailers, creators, and influencers engage their customers, clients, fans, and followers across multiple social media channels simultaneously. GO FUND YOURSELF is an interactive social crowd funding platform and TV show for public and private companies seeking broad-based exposure across social media channels for their crowd-funded Regulation CF and Regulation A issuers; and a telehealth business unit that comprises two wellness-focused ecommerce sites, VanityPrescribed and GoodGirlRX. It operates in the Technology sector.

Ton Strategy Co (TONX) is a good buy right now due to its current price of 3.25, which is significantly below its Fibonacci resistance levels, particularly the R1 at 3.425. The stock has shown a 5-day change of +6.21% and a year-to-date change of +34.85%, indicating positive momentum. Additionally, the company has initiated a buyback program under a $250 million authorization, which is expected to enhance shareholder value and reflects management's confidence in the stock's undervaluation. However, the main risk is the negative earnings trend, with a net income loss of -91,038,000 in Q1 2026, which investors should monitor closely.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis